Myrexis, Inc. 3
3 · ENZON PHARMACEUTICALS, INC. · Filed Mar 31, 2020
Insider Transaction Report
Form 3
Myrexis, Inc.
10% Owner
Holdings
- 250
Common Stock, $0.01 par value
Footnotes (1)
- [F1]The Reporting Person may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by other members of the Section 13(d) group and this report shall not be deemed an admission that it is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.